(Q44397043)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12685616%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

A dose-ranging study of a new, once-daily, dual-component drug product containing niacin extended-release and lovastatin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12685616%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

Donald B Hunninghake

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12685616%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Mark E McGovern

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12685616%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Michael Koren

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12685616%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Ronald Brazg

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12685616%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

David Murdock

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12685616%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Stuart Weiss

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12685616%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Thomas Pearson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12685616%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 March 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12685616%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12685616%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12685616%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12685616%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

112-118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12685616%20AND%20SRC:MED&resulttype=core&format=json

Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies

2 November 2019

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FCLC.4960260304

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

21 January 2018

1 reference

12 December 2020

Treatment Effect of Niaspan, a Controlled-release Niacin, in Patients With Hypercholesterolemia: A Placebo-controlled Trial.

1 reference

12 December 2020

Demographics and cardiology, 1950-2050.

1 reference

12 December 2020

Multiple-dose efficacy and safety of an extended-release form of niacin in the management of hyperlipidemia

1 reference

12 December 2020

Clofibrate and niacin in coronary heart disease

1 reference

12 December 2020

Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial

1 reference

12 December 2020

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease

1 reference

12 December 2020

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

1 reference

12 December 2020

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

1 reference

12 December 2020

Myolysis and acute renal failure in a heart-transplant recipient receiving lovastatin

1 reference

12 December 2020

Lovastatin, nicotinic acid, and rhabdomyolysis

1 reference

12 December 2020

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

12 December 2020

Distribution of lipids in 8,500 men with coronary artery disease. Department of Veterans Affairs HDL Intervention Trial Study Group

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

1 reference

12 December 2020

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

12 December 2020

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

12 December 2020

Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia.

1 reference

12 December 2020

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

12 December 2020

Treatment of hyperlipidemia with combined niacin-statin regimens

1 reference

12 December 2020

Identifiers

DOI

10.1002/CLC.4960260304

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12685616%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12685616%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference